Planta Med 2000; 66(4): 329-332
DOI: 10.1055/s-2000-8539
Original Paper
Georg Thieme Verlag Stuttgart · New York

Essential Moiety for Antimutagenic and Cytotoxic Activity of Hederagenin Monodesmosides and Bisdesmosides Isolated from the Stem Bark of Kalopanax pictus

Kyung-Tae Lee1 , Il-Cheol Sohn1 , Hee-Juhn Park2,*, Dong-Wook Kim3 , Geun-Ok Jung4 , Kun-Young Park4
  • 1 College of Pharmacy, Kyung-Hee University, Seoul, Korea
  • 2 Department of Botanical Resources, Sangji University, Wonju, Korea
  • 3 Research Institute for Wakan-Yaku, Toyama Medical and Pharmaceutical University, Toyama, Japan
  • 4 Department of Food and Nutrition, Pusan National University, Pusan, Korea
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Abstract

For the elucidation of the antimutagenic and cytotoxic principles from the stem bark of Kalopanax pictus, seven isolated components of this crude drug were tested in the Ames test and the MTT test. Hederagenin and its monodesmosides, kalopanaxsaponin A and I in addition to its bisdesmosides, kalopanaxsaponin B and H, showed potent antimutagenic activities against aflatoxin B1 (AFB1). However, they had no inhibitory effects on mutagenicity induced by the direct mutagen, N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). This suggested that hederagenin glycosides might effectively prevent the metabolic activation of AFB1 or scavenge the electrophilic intermediate capable of inducing mutation. Hederagenin was found to be an essential moiety for the exhibition of antimutagenicity. Moreover, hederagenin and its 3-O-glycosides were found to be cytotoxic on various tumor cell lines, P-388, L-1210, U-937, HL-60, SNU-5 and HepG2, while 3,28-di-O-glycosides of hederagenin were not cytotoxic. Hence, hederagenin and its 3-O-glycosides could be suitable for cancer treatment chemopreventive drugs.

References

  • 1 Sano  K,, Sanada  S,, Ida  Y,, Shoji  J.. Studies on the constituents of the stem bark of Kalopanax pictus.  Chem. Pharm. Bull.. 1991;;  39 865-70
  • 2 Shao  C-J,, Kasai  R,, Xu  J-D,, Tanaka  O.. Saponins from leaves of Kalopanax septemlobus (Thunb.) Koidz: Structures of kalopanax-saponins La, Lb and Lc.  Chem. Pharm. Bull.. 1989;;  37 3251-2
  • 3 Shao  C-J,, Kasai  R,, Xu  J-D,, Tanaka  O.. Saponins from roots of Kalopanax septemlobus (Thunb.) Koidz., Ciqiu: Structures of kalopanax-saponins C, D, E and F.  Chem. Pharm. Bull.. 1989;;  37 311-4
  • 4 Park  H J,, Lee  K T,, Jung  W T,, Choi  J W,, Kadota  S.. Protective effects of syringin isolated from Kalopanax pictus on galactosamine induced hepatotoxicity.  Natural medicine. 1999;;  53 113-7
  • 5 Park  H-J,, Kim  D-H,, Choi  J-W,, Park  J-H,, Han  Y-N.. A potent anti-diabetic agent from Kalopanax pitus.  Arch. Pharm. Res.. 1998;;  21 24-9
  • 6 Kim  D-H,, Yu  K-W,, Bae  E-A,, Park  H-J,, Choi  J-W.. Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites.  Biol. Pharm. Res.. 1998;;  21 360-5
  • 7 Kim  D-W,, Bang  K-H,, Rhee  Y-H,, Lee  K-T,, Park  H-J.. Growth inhibitory activities of kalopanaxsaponins A and I against human pathogenic fungi.  Arch. Pharm. Res.. 1998;;  21 688-91
  • 8 Majester-Savornin  B,, Elias  R,, Diaz-Lanza  A M,, Balansard  G,, Gasquet  M,, Delmas  F.. Saponins of the ivy plant, Hedera helix, and their leishmanicidic activity.  Planta Med.. 1991;;  57 260-2
  • 9 Trute  A,, Gross  J,, Mutschler  E,, Nahrstedt  A.. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. .  Planta Med.. 1996;;  63 125-9
  • 10 Danloy  S,, Quetin-Leclercq  J,, Coucke  P,, De Pauw-Gillet  M C,, Elias  R,, Balansard  G et al.. Effects of α-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. .  Planta Med.. 1994;;  60 45-9
  • 11 Lee  H,, Lin  J Y.. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine.  Mutat. Res.. 1988;;  204 229-34
  • 12 Maron  D M,, Ames  B N.. Revised methods for the Salmonella mutagenicity test.  Mutat. Res.. 1983;;  113 173-215
  • 13 Matsushima  T,, Sugimura  T,, Nagao  M,, Yahagi  T,, Shirai  A,, Sawamura  M.. Short-term Tests for Detecting Carcinogens,. In: Norpoth KH, Garner RC, editors Springer Verlag, Berlin; 1980: 273 - 85
  • 14 Denizot  F,, Lang  R J.. Rapid colorimetric assay for cell growth and survival: modification to the tetrazolium dye procedure giving improved sensitivity and reliability.  J. Immun. Methods. 1996;;  89 271-7
  • 15 Young  H S,, Chung  H Y,, Lee  C K,, Park  K Y,, Yokozawa  T,, Oura  H.. Ursolic acid inhibits aflatoxin B1-induced mutagenicity in a Salmonella assay system.  Biol. Pharm. Bull.. 1994;;  17 990-2
  • 16 Sindambiwe  J B,, Calomme  M,, Geerts  S,, Pieters  L,, Vlietinck  A J,, Vanden Berghe  D A.. Evaluation of biological activities of triterpenoid sponins from Maesa lanceolata. .  J. Nat. Prod.. 1998;;  61 585-90
  • 17 Saito  S,, Erashi  J,, Sumita  S,, Furimoto  T,, Nagamura  Y,, Nishida  K et al.. Pharmacological actions of saikosaponins isolated from Bupleurum falcatum. .  Chem. Pharm. Bull.. 1993;;  41 1395-401
  • 18 Abe  H,, Sakaguchi  M,, Yamada  M,, Arichi  S,, Odashima  S.. Pharmacological actions of saikosaponins isolated from Bupleurum falcatum. .  Planta Med.. 1980;;  40 366-72
  • 19 Jeong  H G,, Park  H Y.. The prevention of carbon tetrachloride-induced hepatotoxicity in mice by α-hederin: inhibition of cytochrome P450 2E1 expression.  Biochem. Mol. Biol. In.. 1998;;  45 163-70
  • 20 Paik  K J,, Jeon  S S,, Chung  H Y,, Lee  K H,, Kim  K W,, Chung  J K et al.. Induction of differentiation of the cultured rat mammary epithelial cells by triterpene acids.  Arch. Pharm. Res.. 1998;;  21 398-405

Hee-Juhn Park

Department of Botanical Resources Sangji University

Wonju, 220-702

Korea

Email: hjpark@chiak.sangji.ac.kr

Phone: +82-371-730-0564

Fax: +82-371-730-0564

    >